ACR Convergence 2020

November 5-9, 2020. All Virtual.

View by Number View by Title View Sessions

View by Date

Friday, November 6, 2020

9:00AM-11:00AM: Epidemiology & Public Health Poster I: COVID-19 & Rheumatic Disease

9:00AM-11:00AM: Fibromyalgia & Other Clinical Pain Syndromes Poster

9:00AM-11:00AM: Genetics, Genomics & Proteomics Poster

9:00AM-11:00AM: Healthcare Disparities in Rheumatology Poster

9:00AM-11:00AM: Innate Immunity Poster

9:00AM-11:00AM: Miscellaneous Rheumatic & Inflammatory Diseases Poster I: Diagnosis and Testing

9:00AM-11:00AM: Osteoporosis & Metabolic Bone Disease Poster

9:00AM-11:00AM: Patient Outcomes, Preferences, & Attitudes Poster I: RA, Spondyloarthritis, & OA

9:00AM-11:00AM: Pediatric Rheumatology – Basic Science Poster

9:00AM-11:00AM: RA – Diagnosis, Manifestations, & Outcomes Poster I: Multimorbidity

9:00AM-11:00AM: RA – Treatments Poster I: RA Treatments & Their Safety

9:00AM-11:00AM: SLE – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Manifestations

9:00AM-11:00AM: SLE – Etiology & Pathogenesis Poster

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster I: Psoriatic Arthritis

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster I

9:00AM-11:00AM: Systemic Sclerosis & Related Disorders – Clinical Poster I

9:00AM-11:00AM: Vasculitis – Non-ANCA-Associated & Related Disorders Poster I

10:00AM-10:50AM: Imaging of Rheumatic Diseases (0444–0448)

10:00AM-10:50AM: Infection-related Rheumatic Disease (0454–0458)

10:00AM-10:50AM: Miscellaneous Rheumatic & Inflammatory Diseases I: Mechanisms of Disease (0459–0463)

10:00AM-10:50AM: Professional Education (0474–0478)

11:30AM-1:00PM: Plenary Session I (0429–0433)

3:00PM-3:50PM: Immunological Complications of Therapy (0449–0453)

3:00PM-3:50PM: RA – Diagnosis, Manifestations, & Outcomes I: Pre-Onset & Early RA (0479–0483)

3:00PM-3:50PM: Spondyloarthritis Including Psoriatic Arthritis – Treatment I: Psoriatic Arthritis (0504–0508)

3:00PM-3:50PM: Vasculitis – Non-ANCA-Associated & Related Disorders I: GCA, Behçet’s, & Relapsing Polychondritis (0509–0513)

4:00PM-4:50PM: Clinical Practice I (0434–0438)

4:00PM-4:50PM: Healthcare Disparities in Rheumatology (0439–0443)

4:00PM-4:50PM: RA – Diagnosis, Manifestations, & Outcomes II: The Heart of the Matter (0484–0488)

4:00PM-4:50PM: Vasculitis – Non-ANCA-Associated & Related Disorders II: GCA Clinical & Epidemiology (0514–0518)

5:00PM-5:50PM: Patient Outcomes, Preferences, & Attitudes I: COVID-19 (0464–0468)

5:00PM-5:50PM: Pediatric Rheumatology – Basic Science (0469–0473)

5:00PM-5:50PM: RA – Diagnosis, Manifestations, & Outcomes III: Major Comorbidities in RA (0489–0493)

5:00PM-5:50PM: SLE – Etiology & Pathogenesis (0494–0498)

5:00PM-5:50PM: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes I: Psoriatic Arthritis (0499–0503)

Saturday, November 7, 2020

9:00AM-11:00AM: Antiphospholipid Syndrome Poster

9:00AM-11:00AM: Epidemiology & Public Health Poster II: OA, Osteoporosis, & Other Rheumatic Disease

9:00AM-11:00AM: Health Services Research Poster

9:00AM-11:00AM: Infection-related Rheumatic Disease Poster

9:00AM-11:00AM: Metabolic & Crystal Arthropathies Poster

9:00AM-11:00AM: Orthopedics, Low Back Pain, & Rehabilitation Poster

9:00AM-11:00AM: Osteoarthritis & Joint Biology – Basic Science Poster

9:00AM-11:00AM: Pediatric Rheumatology – Clinical Poster II: JIA

9:00AM-11:00AM: RA – Animal Models Poster

9:00AM-11:00AM: RA – Diagnosis, Manifestations, & Outcomes Poster II: Biomarkers

9:00AM-11:00AM: RA – Etiology & Pathogenesis Poster

9:00AM-11:00AM: RA – Treatments Poster II: Comparative Effectiveness, Biosimilars, Adherence & the Real World

9:00AM-11:00AM: SLE – Animal Models Poster

9:00AM-11:00AM: SLE – Treatment Poster I

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster II

9:00AM-11:00AM: Systemic Sclerosis & Related Disorders – Clinical Poster II

10:00AM-10:50AM: Fibromyalgia & Other Clinical Pain Syndromes (0940–0944)

10:00AM-10:50AM: Innate Immunity (0945–0949)

10:00AM-10:50AM: Muscle Biology, Myositis & Myopathies (0955–0959)

10:00AM-10:50AM: Orthopedics, Low Back Pain, & Rehabilitation (0960–0964)

11:30AM-1:00PM: Plenary Session II (0934–0939)

3:00PM-3:50PM: RA – Etiology & Pathogenesis (0970–0974)

3:00PM-3:50PM: SLE – Animal Models (0975–0979)

3:00PM-3:50PM: SLE – Treatment (0985–0989)

5:00PM-5:50PM: Metabolic & Crystal Arthropathies (0950–0954)

5:00PM-5:50PM: RA – Animal Models (0965–0969)

5:00PM-5:50PM: SLE – Diagnosis, Manifestations, & Outcomes I: Morbidity (0980–0984)

Sunday, November 8, 2020

9:00AM-11:00AM: B Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

9:00AM-11:00AM: Epidemiology & Public Health Poster III: Inflammatory Rheumatic Disease

9:00AM-11:00AM: Miscellaneous Rheumatic & Inflammatory Diseases Poster II: Sarcoidosis, Interstitial Lung Disease, & Inflammatory Eye Disease

9:00AM-11:00AM: Muscle Biology, Myositis & Myopathies Poster

9:00AM-11:00AM: Osteoarthritis – Clinical Poster I

9:00AM-11:00AM: Patient Outcomes, Preferences, & Attitudes Poster II: Miscellaneous Rheumatic Diseases

9:00AM-11:00AM: Patient Perspectives Poster

9:00AM-11:00AM: Pediatric Rheumatology – Clinical Poster II: Systemic JIA, Autoinflammatory, & Scleroderma

9:00AM-11:00AM: RA – Diagnosis, Manifestations, & Outcomes Poster III: Cardiopulmonary Aspects

9:00AM-11:00AM: RA – Treatments Poster III: PROs, Biomarkers, Systemic Inflammation & Radiographs

9:00AM-11:00AM: Sjögren’s Syndrome Poster

9:00AM-11:00AM: SLE – Diagnosis, Manifestations, & Outcomes Poster II: Comorbidities

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II: Extra-MSK & Comorbidities

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster III

9:00AM-11:00AM: Systemic Sclerosis & Related Disorders – Clinical Poster III

9:00AM-11:00AM: T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

9:00AM-11:00AM: Vasculitis – ANCA-Associated Poster

10:00AM-10:50AM: B Cell Biology & Targets in Autoimmune & Inflammatory Disease (1452–1456)

10:00AM-10:50AM: Clinical Practice II (1457–1461)

10:00AM-10:50AM: Miscellaneous Rheumatic & Inflammatory Diseases II: Evaluating Drug Therapies for COVID-19 (1477–1481)

11:30AM-1:00PM: Plenary Session III (1441–1446)

12:00PM-1:00PM: Patient Perspectives (PP09–PP12)

3:00PM-3:50PM: Epidemiology & Public Health I: RA (1462–1466)

3:00PM-3:50PM: Reproductive Issues in Rheumatic Disorders (1497–1501)

3:00PM-3:50PM: SLE – Diagnosis, Manifestations, & Outcomes II: Bench to Bedside (1507–1511)

3:00PM-3:50PM: Systemic Sclerosis & Related Disorders – Basic Science (1522–1526)

4:00PM-4:50PM: Antiphospholipid Syndrome (1447–1451)

4:00PM-4:50PM: Epidemiology & Public Health II: Risk Factors & Outcomes (1467–1471)

4:00PM-4:50PM: Osteoarthritis I: Clinical Trials (1482–1486)

4:00PM-4:50PM: Pediatric Rheumatology – Clinical I: Treatment of JIA (1492–1496)

4:00PM-4:50PM: SLE – Diagnosis, Manifestations, & Outcomes III: Lupus Nephritis (1512–1516)

5:00PM-5:50PM: Epidemiology & Public Health III: Risk Factors & Outcomes (1472–1476)

5:00PM-5:50PM: Osteoarthritis II: Clinical Aspects (1487–1491)

5:00PM-5:50PM: Sjögren’s Syndrome (1502–1506)

5:00PM-5:50PM: Spondyloarthritis Including Psoriatic Arthritis – Basic Science (1517–1521)

Monday, November 9, 2020

9:00AM-11:00AM: Cytokines & Cell Trafficking Poster

9:00AM-11:00AM: Imaging of Rheumatic Diseases Poster

9:00AM-11:00AM: Immunological Complications of Therapy Poster

9:00AM-11:00AM: Measures & Measurement of Healthcare Quality Poster

9:00AM-11:00AM: Miscellaneous Rheumatic & Inflammatory Diseases Poster III: Therapies

9:00AM-11:00AM: Osteoarthritis – Clinical Poster II

9:00AM-11:00AM: Pediatric Rheumatology – Clinical Poster III: SLE, Vasculitis, & JDM

9:00AM-11:00AM: Professional Education Poster

9:00AM-11:00AM: RA – Diagnosis, Manifestations, & Outcomes Poster IV: Lifespan of a Disease

9:00AM-11:00AM: Reproductive Issues in Rheumatic Disorders Poster

9:00AM-11:00AM: SLE – Diagnosis, Manifestations, & Outcomes Poster III: Bench to Bedside

9:00AM-11:00AM: SLE – Treatment Poster II

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III: Axial SpA

9:00AM-11:00AM: Systemic Sclerosis & Related Disorders – Basic Science Poster

9:00AM-11:00AM: Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

10:00AM-10:50AM: Health Services Research (1958–1962)

10:00AM-10:50AM: Pediatric Rheumatology – Clinical II: Outcomes & Care Delivery (1983–1987)

10:00AM-10:50AM: RA – Treatments I: Maximizing Health in RA (1993–1997)

10:00AM-10:50AM: T Cell Biology & Targets in Autoimmune & Inflammatory Disease (2043–2047)

11:00AM-11:50AM: Patient Outcomes, Preferences, & Attitudes II: Engagement, Perceptions, & Quality of Life (1978–1982)

11:00AM-11:50AM: Pediatric Rheumatology – Clinical III: Systemic Autoimmune Disease (1988–1992)

11:00AM-11:50AM: Spondyloarthritis Including Psoriatic Arthritis – Treatment II: Emerging Therapies (2023–2027)

11:00AM-11:50AM: Vasculitis – ANCA-Associated (2048–2052)

12:00PM-12:50PM: Genetics, Genomics & Proteomics (1953–1957)

12:00PM-12:50PM: Measures & Measurement of Healthcare Quality (1963–1967)

12:00PM-12:50PM: Osteoarthritis & Joint Biology – Basic Science (1968–1972)

12:00PM-12:50PM: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes II (2013–2017)

3:00PM-3:50PM: Cytokines & Cell Trafficking (1948–1952)

3:00PM-3:50PM: Osteoporosis & Metabolic Bone Disease (1973–1977)

3:00PM-3:50PM: RA – Treatments II: Potential Harms & Adverse Events (1998–2002)

3:00PM-3:50PM: Systemic Sclerosis & Related Disorders – Clinical I: Stratification Strategies for Clinical Trials (2033–2037)

4:00PM-4:50PM: RA – Treatments III: Predictors of Treatment Response (2003–2007)

4:00PM-4:50PM: Spondyloarthritis Including Psoriatic Arthritis – Treatment III: Axial Spondyloarthritis (2028–2032)

4:00PM-4:50PM: Systemic Sclerosis & Related Disorders – Clinical II: Lessons Learned from Clinical Trials & Cohorts (2038–2042)

5:00PM-5:50PM: RA – Treatments IV: New Therapies & Strategies (2008–2012)

5:00PM-5:50PM: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes III: Imaging in SpA (2018–2022)